Platelet-to-lymphocyte ratio and CA 19-9 are simple and informative prognostic factors in patients with resected pancreatic cancer

[1]  Y. Fujiwara,et al.  Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[2]  M. Plebani,et al.  Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity , 2019, International journal of molecular sciences.

[3]  Paula Esther Moraga-Serrano.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic Analysis for the Global Burden of Disease Study , 2018 .

[4]  T. Gocho,et al.  C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer , 2018, AntiCancer Research.

[5]  J. Pyo,et al.  Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio , 2018, Gastroenterology research and practice.

[6]  N. Kuriyama,et al.  Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer , 2018, Cancers.

[7]  M. Beuran,et al.  Surgical Anatomy of the Superior Mesenteric Vessels Related to Pancreaticoduodenectomy: a Systematic Review and Meta-Analysis , 2018, Journal of Gastrointestinal Surgery.

[8]  M. Beuran,et al.  MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer - A systematic review and meta-analysis. , 2017, American journal of surgery.

[9]  Chuan Tian,et al.  Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis , 2017, PloS one.

[10]  D. Kruger,et al.  Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: A preliminary report. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[11]  T. Luedde,et al.  Current and future biomarkers for pancreatic adenocarcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[12]  M. Beuran,et al.  Superior mesenteric artery first approach versus standard pancreaticoduodenectomy: a systematic review and meta-analysis. , 2017, Hepatobiliary & pancreatic diseases international : HBPD INT.

[13]  L. Munn.  Cancer and inflammation , 2017, Wiley interdisciplinary reviews. Systems biology and medicine.

[14]  D. Kruger,et al.  Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review , 2016, PloS one.

[15]  M. Beuran,et al.  The epithelial to mesenchymal transition in pancreatic cancer: A systematic review. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[16]  Yunpeng Liu,et al.  Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study , 2014, World Journal of Surgical Oncology.

[17]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[18]  U. Ballehaninna,et al.  The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. , 2012, Journal of gastrointestinal oncology.

[19]  P. Bottoni,et al.  CA 19-9: Biochemical and Clinical Aspects. , 2015, Advances in experimental medicine and biology.

[20]  Y. Sakamoto,et al.  Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer , 2011, Annals of Surgical Oncology.

[21]  L. Schneck.  Biochemical and Clinical Aspects , 1975 .